Radiotherapy in the adjuvant setting of cervical carcinoma: treatment, results, and prognostic factors

被引:5
|
作者
Atahan, I. L.
Yildiz, F. [1 ]
Ozyar, E.
Pehlivan, B.
Genc, M.
Kose, M. F.
Tulunay, G.
Ayhan, A.
Yuce, K.
Guler, N.
Kucukali, T.
机构
[1] Hacettepe Univ, Fac Med, Dept Radiat Oncol, TR-06100 Ankara, Turkey
[2] Selcuk Univ, Fac Med, Dept Radiat Oncol, Konya, Turkey
[3] SSK Ankara Matern & Womens Hlth Teaching Hosp, Dept Gynecol Oncol, Ankara, Turkey
[4] Hacettepe Univ, Fac Med, Dept Med Oncol, TR-06100 Ankara, Turkey
[5] Hacettepe Univ, Fac Med, Dept Pathol, TR-06100 Ankara, Turkey
[6] Hacettepe Univ, Fac Med, Dept Obstet & Gynecol, TR-06100 Ankara, Turkey
关键词
cervical cancer; prognostic factors; radiotherapy;
D O I
10.1111/j.1525-1438.2007.00887.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To evaluate the efficacy of postoperative radiotherapy and to investigate prognostic factors for early-stage cervical cancer patients. From December 1993 to December 2001, 141 patients with stage I-II cervical cancer without para-aortic lymph node (LN) metastases and treated by surgery and postoperative radiotherapy (RT) were included in this study. Indications for postoperative external RT were based on pathologic findings, including LN metastasis, positive surgical margins, parametrial involvement, pT2 tumor, and presence of any two minor risk factors like lymphvascular space involvement, deep stromal invasion, and tumor diameter between 2-4 cm. Sixty-six (47%) patients received RT alone, whereas 59 (42%) were treated with RT and concomitant chemotherapy (CT), and 16 received neoadjuvant CT. Patients with positive vaginal margins also received 27.5 Gy high-dose rate vaginal cuff brachytherapy in five fractions. Median follow-up time was 55 months. The actuarial 5-year overall (OS), disease-free (DFS), locoregional recurrence-free (LRFS), and distant metastases-free (DMFS) survival rates are 70%, 68%, 77%, and 88%, respectively. Univariate and multivariate analyses revealed that level and number of metastatic LNs and concomitant CT were unique significant prognostic factors for OS, DFS, and LRFS. Endometrial involvement, on the other hand, was proven to be significant for DFS and DMFS. Patients with less than three LN metastases or having only obturator LN involvement showed similar prognosis with their counterparts having no LN metastases. On the other hand, patients with either common iliac LN or more than three LN metastases had significantly worse outcome. Our results indicate that level and number of metastatic LNs are the most important prognostic factors determining the survival rates, and patients with upper lymphatic involvement or more than three metastatic LNs seem to need more effective treatment approaches.
引用
收藏
页码:813 / 820
页数:8
相关论文
共 50 条
  • [1] Radiotherapy in the adjuvant setting of cervical carcinoma: Treatment results and prognostic factors
    Atahan, I. L.
    Yildiz, F.
    Ozyar, E.
    Pehlivan, B.
    Kose, F.
    Tulunay, G.
    Ayhan, A.
    Yuce, K.
    Guler, N.
    Kucukali, T.
    EJC SUPPLEMENTS, 2005, 3 (02): : 275 - 275
  • [2] Radiotherapy in the adjuvant setting of cervical carcinoma: Treatment results and prognostic factors
    Yildiz, F.
    Atahan, I. L.
    Ozyar, E.
    Pehlivan, B.
    Genc, M.
    Kose, F.
    Ayhan, A.
    Guler, N.
    Tolunay, G.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S329 - S330
  • [3] Adjuvant radiotherapy in thymic epithelial tumor: treatment results and prognostic factors
    Kundel, Yulia
    Yellin, Alon
    Pfeffer, Raphael
    Simansky, David A.
    Oberman, Bernice
    Sadezki, Siegal
    Catane, Raphael
    Levitt, Mark L.
    ANNALS OF ONCOLOGY, 2004, 15 : 170 - 171
  • [4] Adjuvant radiotherapy for thymic epithelial tumor - Treatment results and prognostic factors
    Kundel, Yulia
    Yellin, Alon
    Popovtzer, Aron
    Pfeffer, Raphael
    Symon, Zvi
    Simansky, David A.
    Oberman, Bernice
    Sadezki, Siegal
    Brenner, Baruch
    Catane, Raphael
    Levitt, Mark L.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (04): : 389 - 394
  • [5] POSTOPERATIVE RADIOTHERAPY IN CARCINOMA OF THE CERVIX - TREATMENT RESULTS AND PROGNOSTIC FACTORS
    ATKOVAR, G
    UZEL, O
    OZSAHIN, M
    KOCA, S
    SAHINLER, I
    OKKAN, S
    UZEL, R
    RADIOTHERAPY AND ONCOLOGY, 1995, 35 (03) : 198 - 205
  • [6] Postoperative radiotherapy in thymic carcinoma: Treatment results and prognostic factors
    Hsu, HC
    Huang, EY
    Wang, CJ
    Sun, LM
    Chen, HC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03): : 801 - 805
  • [7] Prognostic factors in endometrial carcinoma: risk groups and adjuvant radiotherapy
    GarciaDomenech, RV
    Inesta, JM
    Asins, E
    Aznar, I
    Llixiona, J
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1997, 18 (03) : 164 - 170
  • [8] Treatment results of radiotherapy for carcinoma of the cervical esophagus
    Yamada, Kazunari
    Murakami, Masao
    Okamoto, Yoshiaki
    Okuno, Yoshishige
    Nakajima, Toshifumi
    Kusumi, Fusako
    Takakuwa, Hiroshi
    Matsusue, Satoru
    ACTA ONCOLOGICA, 2006, 45 (08) : 1120 - 1125
  • [9] Evaluation of treatment results and prognostic factors in early-stage cervical carcinoma patients treated with postoperative radiotherapy or radiochemotherapy
    Demirci, S.
    Ozsaran, Z.
    Ozsaran, A.
    Yavas, F.
    Demircioglu, B.
    Hanhan, M.
    Dikmen, Y.
    Aras, A. B.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (01) : 62 - 67
  • [10] Comparison of no adjuvant treatment and radiotherapy in early-stage cervical carcinoma with intermediate risk factors
    Akilli, Huseyin
    Tohma, Yusuf A.
    Bulut, Ayca N.
    Karakas, Latife Atasoy
    Haberal, Asuman N.
    Kuscu, Ulku E.
    Ayhan, Ali
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2020, 149 (03) : 298 - 302